OKUR
OnKure Therapeutics, Inc.
2.40$
-4.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -72.6% | -31.4% | +3.9% | +204.8% | +48.0% | -13.1% | -13.8% | -15.4% | -14.7% | +219.9% | -9.7% | |
| – | -73.8% | -32.7% | +4.8% | +223.6% | +46.8% | -13.1% | -13.9% | -15.4% | -14.9% | +224.6% | -10.0% | |
| – | +154.5% | -35.6% | -3.2% | +225.7% | +82.5% | -12.7% | -13.7% | -15.6% | -16.0% | +225.3% | -13.3% | |
| – | -76.2% | -35.6% | -3.2% | +311.5% | +44.5% | -12.7% | -13.7% | -15.6% | -16.0% | +225.3% | -8.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +790.8% | -1.3% | +9.8% | -97.6% | +205.5% | -16.7% | -14.4% | -18.9% | -7.4% | +141.7% | -49.5% | |
| – | -46.3% | -23.8% | +133.9% | -75.0% | +224.2% | -16.6% | -13.5% | -17.8% | -5.2% | +142.0% | -53.6% | |
| – | -36.0% | +1.9% | +1.9% | +32.4% | +87.4% | +1.9% | +1.8% | +2.0% | -3.2% | -25.5% | -17.8% | |
| – | +38.2% | +6.0% | +128.0% | -97.1% | +1,152.3% | -21.0% | +1.6% | -45.8% | +11.1% | +669.2% | -81.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -188.6% | – | – | – | +40.3% | -12.7% | -13.8% | -15.0% | -15.4% | +228.1% | -6.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.6% | +0.6% | +0.0% | +0.1% | +1.2% | +264.7% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.